Amanote Research

Amanote Research

    RegisterSign In

“To Patent or Not to Patent? The Case of Novartis’ Cancer Drug Glivec in India”

Globalization and Health - United Kingdom
doi 10.1186/1744-8603-10-3
Full Text
Open PDF
Abstract

Available in full text

Categories
Health PolicyPublic HealthOccupational HealthEnvironmental
Date

January 1, 2014

Authors
Ravinder GabbleJillian Kohler
Publisher

Springer Science and Business Media LLC


Related search

Court Dismisses Novartis Challenge to Indian Patent Law

BMJ
2007English

AIDS Drug Patent

Nature
Multidisciplinary
1988English

Patent Foramen Ovale in Cryptogenic Stroke: Not to Close

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Rationalizing the Drug Patent System

Health Affairs
MedicineHealth Policy
2001English

ABC's of Patent : Part2: How to Patent an Idea of Namafuku

Journal of Information Processing and Management
2008English

The Scramble to Patent Human Genes

Nature Neuroscience
Neuroscience
1999English

Text Mining Technology for Patent Analysis and Patent Search : Patent Search and Patent Analysis Service Patent Integration

Journal of Information Processing and Management
2010English

Nonexclusive Patent Licensees Unite: Use Bankruptcy Committees to Sue for Patent Infringement

Duke Law Journal
Law
1998English

Text Matching to Measure Patent Similarity

Strategic Management Journal
ManagementInternational ManagementBusinessStrategy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy